STERIS Net Change in Short-term Investments 2010-2025 | STE
STERIS annual/quarterly net change in short-term investments history and growth rate from 2010 to 2025. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
- STERIS net change in short-term investments for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
- STERIS net change in short-term investments for the twelve months ending March 31, 2025 was $-0.002B, a 0% increase year-over-year.
- STERIS annual net change in short-term investments for 2024 was $-0.002B, a 0% decline from 2023.
- STERIS annual net change in short-term investments for 2023 was $0B, a 0% decline from 2022.
- STERIS annual net change in short-term investments for 2022 was $0B, a 100% decline from 2021.
| STERIS Annual Net Change in Short-term Investments (Millions of US $) |
|
|---|---|
| 2024 | $-2 |
| 2023 | $N/A |
| 2022 | $N/A |
| 2021 | $-4 |
| 2020 | $N/A |
| 2019 | $-5 |
| 2018 | $N/A |
| 2017 | $-6 |
| 2016 | $N/A |
| 2015 | $-5 |
| 2014 | $N/A |
| 2013 | $N/A |
| 2012 | $N/A |
| 2011 | $N/A |
| 2010 | $N/A |
| 2009 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $24.092B | $5.460B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.969B | 86.71 |
| Thermo Fisher Scientific (TMO) | United States | $152.062B | 18.39 |
| Edwards Lifesciences (EW) | United States | $45.884B | 30.08 |
| Alcon (ALC) | Switzerland | $42.389B | 28.65 |
| IDEXX Laboratories (IDXX) | United States | $41.285B | 47.45 |
| DexCom (DXCM) | United States | $33.643B | 52.00 |
| IQVIA Holdings (IQV) | United States | $24.277B | 13.60 |
| Mettler-Toledo (MTD) | United States | $24.015B | 28.56 |
| Waters (WAT) | United States | $20.783B | 29.32 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.675B | 0.00 |
| Hologic (HOLX) | United States | $13.854B | 15.05 |
| Sysmex ADR (SSMXY) | Japan | $10.550B | 29.93 |
| Penumbra (PEN) | United States | $10.339B | 81.15 |
| Masimo (MASI) | United States | $8.811B | 32.50 |
| Globus Medical (GMED) | United States | $8.012B | 19.09 |
| Teleflex (TFX) | United States | $5.403B | 8.92 |
| Glaukos (GKOS) | United States | $5.388B | 0.00 |
| TransMedics (TMDX) | United States | $4.300B | 93.47 |
| Integer Holdings (ITGR) | United States | $4.144B | 21.71 |
| PROCEPT BioRobotics (PRCT) | United States | $3.209B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.358B | 14.04 |
| Veracyte (VCYT) | United States | $2.084B | 29.24 |
| Nihon Kohden (NHNKY) | Japan | $2.062B | 23.65 |
| Elekta AB (EKTAY) | Sweden | $1.996B | 17.94 |
| Alphatec Holdings (ATEC) | United States | $1.817B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.320B | 0.00 |
| Artivion (AORT) | United States | $1.263B | 118.32 |
| Pulse Biosciences (PLSE) | United States | $1.164B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.984B | 5.23 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.747B | 0.00 |
| IRadimed (IRMD) | United States | $0.736B | 37.34 |
| RxSight (RXST) | United States | $0.621B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.581B | 9.04 |
| Delcath Systems (DCTH) | United States | $0.565B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.549B | 12.87 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.485B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.446B | 11.87 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.441B | 0.00 |
| NeuroPace (NPCE) | United States | $0.434B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.414B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.361B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.331B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.289B | 0.00 |
| Neuronetics (STIM) | United States | $0.257B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.92 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| 908 Devices (MASS) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| CVRx (CVRX) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Accuray (ARAY) | United States | $0.158B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.153B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.153B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.146B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.60 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.23 |